A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

WIDEX MOMENT™ Hearing Aids Named CES 2021 Innovation Awards Honoree: Earns Recognition In Health & Wellness and Wearable Technologies Categories

Widex Inc. today announced that it has been named a CES® 2021 Innovation Awards Honoree for the company’s WIDEX MOMENT™ natural-sounding hearing aids. The announcement comes ahead of the first-ever, all-digital CES 2021, happening Jan. 11-14, 2021.

WIDEX MOMENT was selected as an honoree in the CES 2021 Innovation Awards Health & Wellness and Wearable Technologies categories for its groundbreaking solution, which is the first digital hearing aid to incorporate dual artificial intelligence engines to improve real-time listening. Furthermore, the WIDEX MOMENT leverages ZeroDelay technology to reduce the standard sound delay from 7-10 milliseconds seconds to 0.5 milliseconds, creating natural sound that transforms how people with hearing loss experience the world.

“Widex engineers have worked tirelessly over five years to create a unique, natural hearing platform like WIDEX MOMENT,” said Søren Hvidberg Nielsen, President of Widex US. “Hearing aids aren’t only used to amplify speech. For people who benefit from them, they open a far wider aural window onto the lives they want to experience. We are grateful the CES Innovation Awards judges recognized the incredible potential of WIDEX MOMENT as a wearable and wellness device.”

The WIDEX MOMENT utilizes artificial intelligence to create a better sound experience that leads to higher user acceptance. The device’s SoundSense Learn technology adjusts hearing aid settings in two ways using artificial intelligence. First, WIDEX MOMENT learns how users prefer to hear their surroundings by analyzing settings and guiding them through a series of A-B comparisons. Second, they draw from millions of user settings stored in the cloud to help personalize the listening experience.

WIDEX MOMENT hearing aids also include Widex PureSound™ ZeroDelay™ technology, a groundbreaking parallel processing path that all but eliminates latency, resulting in a more natural sound without the “tinny” distortions associated with other hearing aids. By reducing processing latency to just 0.5 milliseconds, Widex ZeroDelay provides users with a new level of clear, natural sound that wasn’t possible in older devices.

The CES Innovation Awards program, owned and produced by the Consumer Technology Association (CTA)®, is an annual competition honoring outstanding design and engineering in consumer technology products across 28 product categories. An elite panel of industry expert judges, including members of the media, designers, engineers and more, reviewed submissions based on innovation, engineering and functionality, aesthetic and design.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy